Nexthera Capital

Nexthera Capital as of June 30, 2016

Portfolio Holdings for Nexthera Capital

Nexthera Capital holds 35 positions in its portfolio as reported in the June 2016 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Pfizer (PFE) 19.1 $22M 626k 35.21
GlaxoSmithKline 17.6 $20M 470k 43.34
Shire 11.8 $14M 74k 184.08
Seattle Genetics 5.3 $6.1M 152k 40.41
Mylan Nv 5.2 $6.1M 140k 43.24
Lannett Company 4.7 $5.5M 230k 23.79
Amgen (AMGN) 4.0 $4.6M 30k 152.17
Cynapsus Therapeutics 3.5 $4.1M 244k 16.75
Acceleron Pharma 2.9 $3.4M 99k 33.98
Aquinox Pharmaceuticals 2.9 $3.3M 498k 6.62
Adamas Pharmaceuticals 2.3 $2.7M 178k 15.14
Fibrogen 2.2 $2.5M 154k 16.41
Concert Pharmaceuticals I equity 1.8 $2.1M 183k 11.23
Aerie Pharmaceuticals 1.7 $1.9M 110k 17.60
Array BioPharma 1.6 $1.9M 521k 3.56
Insmed (INSM) 1.4 $1.7M 169k 9.86
Edge Therapeutics 1.2 $1.4M 136k 10.11
Ignyta 1.1 $1.3M 235k 5.42
Minerva Neurosciences 0.9 $1.1M 107k 10.21
Advaxis 0.9 $1.0M 125k 8.09
Alder Biopharmaceuticals 0.8 $974k 39k 24.97
Trevena 0.8 $945k 150k 6.30
Tobira Therapeutics Inc Common Stock Usd 0.0001 0.8 $942k 75k 12.56
Foamix Pharmaceuticals 0.8 $922k 145k 6.35
Uniqure Nv (QURE) 0.6 $688k 93k 7.37
Immune Design 0.6 $695k 85k 8.16
Scynexis 0.5 $597k 275k 2.17
Vistagen Therapeutics 0.5 $539k 138k 3.90
AVEO Pharmaceuticals 0.4 $497k 518k 0.96
Verastem 0.4 $437k 336k 1.30
ImmunoGen 0.4 $433k 141k 3.08
Progenics Pharmaceuticals 0.3 $405k 96k 4.22
Zynerba Pharmaceuticals 0.3 $391k 57k 6.85
Eiger Biopharmaceuticals 0.2 $277k 14k 19.79
Abeona Therapeutics 0.2 $236k 100k 2.36